The present disclosure relates to 5H-Pyrrolo[3,2-d]pyrimidine-2,4-diamino compounds, and/or antibody conjugates thereof; and pharmaceutical compositions thereof, methods of producing the conjugates, and methods of using the conjugates and compositions for therapy.
本公开涉及5H-Pyrrolo[3,2-d]pyrimidine-2,4-二
氨基化合物及/或其
抗体偶联物;以及其制备的药物组合物,制备偶联物的方法,以及使用偶联物和组合物进行治疗的方法。